• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Pfizer

Pfizer

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. Advisory Committee on Immunization Practices Votes to Recommend Pfizer ’s Prevnar 13® Vaccine in Adults Aged 65 Years and Older

    Advisory Committee on Immunization Practices Votes to Recommend Pfizer ’s Prevnar 13® Vaccine in Adults Aged 65 Years and Older

  2. UPDATE: U.S. stocks: Futures rise after Merck, Pfizer results

    UPDATE: U.S. stocks: Futures rise after Merck, Pfizer results

  3. MARKET SNAPSHOT: U.S. Stocks: Futures Rise After Merck, Pfizer Results

    MARKET SNAPSHOT: U.S. Stocks: Futures Rise After Merck, Pfizer Results

  4. UPDATE: Inversions are not such a sweet deal for fund investors

    UPDATE: Inversions are not such a sweet deal for fund investors

  5. Pfizer PFE Q1 2014 Earnings Call Transcript

    Good day everyone and welcome to Pfizer's First Quarter 2014 Earnings Conference Call. Today's call is being recorded.

  6. Manhattan Scientifics Reaches the Fork (Falk) in the Road

    Manhattan Scientifics Reaches the Fork (Falk) in the Road

  7. Research and Markets: Competitor Analysis: GLP-1 Receptor Agonists Development Pipeline Report 2014

    Research and Markets: Competitor Analysis: GLP-1 Receptor Agonists Development Pipeline Report 2014

  8. Research and Markets: Global Non-Small Cell Lung Cancer Market to 2020: Pipeline Entries to Drive NSCLC Market Growth

    Research and Markets: Global Non-Small Cell Lung Cancer Market to 2020: Pipeline Entries to Drive NSCLC Market Growth

  9. 10 High-Conviction Purchases by the Ultimate Stock-Pickers

    Top managers continue to exercise a lot of patience as they look for buying opportunities in a U.S. equity market that has risen close to 40% since the start of 2013.

  10. UPDATE: Tax inversions can be bad for shareholders -- and for America

    UPDATE: Tax inversions can be bad for shareholders -- and for America

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.